Serious bacterial infections in hospitalized febrile infants aged 90 days or younger: The traditional combination of ampicillin and gentamicin is still appropriate

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 6-7, 2011, Pages 489-494

  Ashkenazi Hoffnung, Liat ^a   Livni, Gilat ^a,b   Amir, Jacob ^a,b   Bilavsky, Efraim ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

ampicillin resistance; bacteraemia; Gram negative bacteria; meningitis; serious bacterial infection; urinary tract infection

Indexed keywords

AMPICILLIN; CEFTAZIDIME; CLAVULANIC ACID; GENTAMICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CAMPYLOBACTER JEJUNI; CHILD HOSPITALIZATION; CITROBACTER FREUNDII; CLINICAL TRIAL; DRUG EFFICACY; ENTERITIS; ENTEROBACTER CLOACAE; ENTEROCOCCUS; EPSILOMETER TEST; ESCHERICHIA COLI; FEMALE; FEVER; HUMAN; IN VITRO STUDY; INFANT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PROSPECTIVE STUDY; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SALMONELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; TREATMENT RESPONSE; URINARY TRACT INFECTION;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG THERAPY, COMBINATION; FEMALE; GENTAMICINS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79959228503     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.555918     Document Type: Article

References (22)

1. th ed. Philadelphia: Saunders; 2007 pp 807-8.
2. Baraff LJ, Bass JW, Fleisher GR, Klein JO, McCracken GH Jr, Powell KR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med 1993;22:1198-210. (Pubitemid 23191038)
3. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9. (Pubitemid 34787629)
4. Trends in perinatal group B streptococcal disease - United States, 2000-2006. MMWR Morb Mortal Wkly Rep 2009;58:109.
5. Tappero JW, Schuchat A, Deaver KA, Mascola L, Wenger JD. Reduction in the incidence of human listeriosis in the United States. Effectiveness of prevention efforts? The Listeriosis Study Group. JAMA 1995;273:1118-22.
6. Brown JC, Burns JL, Cummings P. Ampicillin use in infant fever: a systematic review. Arch Pediatr Adolesc Med 2002;156:27-32. (Pubitemid 34049107)
7. Alarcon A, Peña P, Salas S, Sancha M, Omeñaca F. Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis. Pediatr Infect Dis J 2004;23:295-9. (Pubitemid 38508879)
8. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002;347:240-7. (Pubitemid 34787630)
9. Levine EM, Ghai V, Barton JJ, Strom CM. Intrapartum antibiotic prophylaxis increases the incidence of Gram-negative neonatal sepsis. Infect Dis Obstet Gynecol 1999;7:210-3. (Pubitemid 29379197)
10. Sadow KB, Derr R, Teach SJ. Bacterial infections in infants 60 days and younger: epidemiology, resistance, and implications for treatment. Arch Pediatr Adolesc Med 1999;153:611-4. (Pubitemid 29250232)
11. Committee on Quality Improvement. Subcommittee on Urinary Tract Infections. Practice parameter: the diagnosis, treatment, and evaluation of the initial UTI in febrile infants and young children. Pediatrics 1999;103:843-52.
12. Byington CL, Rittichier KK, Bassett KE, Castillo H, Glasgow TS, Daly J, et al. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics 2003;111:964-8. (Pubitemid 36542607)
13. rd ed. Wayne, PA: CLSI; 2003.
14. Schwartz S, Raveh D, Toker O, Segal G, Godovitch N, Schlesinger Y. A week-by-week analysis of the low-risk criteria for serious bacterial infection in febrile neonates. Arch Dis Child 2009;94:287-92.
15. Glasgow TS, Young PC, Wallin J, Kwok C, Stoddard G, Firth S, et al. Association of intrapartum antibiotic exposure and late-onset serious bacterial infections in infants. Pediatrics 2005;116:696-702. (Pubitemid 44336688)
16. Bizzarro, MJ. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008;121:689-96.
17. Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 1998;42:1517-9.
18. Moellering RC. Emergence of Enterococcus as a significant pathogen. Clin Infect Dis 1992;14:1173-8.
19. Dobson SR, Baker CJ. Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection. Pediatrics 1990;85:165-71.
20. Bachur RG, Harper M. To culture or not to culture: at what age does the urinalysis become a reliable predictor of urinary tract infection in young children? Paper presented at The Society for Pediatric Research, Ambulatory Pediatric Association meeting, San Francisco, California, USA, May 1999.
21. rd ed. New York, NY: Churchill Livingstone; 1990; pp. 214-6.
22. Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001;39:2206-12. (Pubitemid 32531482)